Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.

Cited by (234)

1. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
   Webster, Scott J., Bachstetter, Adam D., Nelson, Peter T., Schmitt, Frederick A., Van Eldik, Linda J. · 2014 · Frontiers in Genetics
2. Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
   Bondi, Mark W., for the Alzheimer's Disease Neuroimaging Initiative, Edmonds, Emily C., Jak, Amy J., Clark, Lindsay R., Delano-Wood, Lisa, McDonald, Carrie R., Nation, Daniel A., Libon, David J., Au, Rhoda et al. · 2014 · Journal of Alzheimer's Disease
3. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
   Bäckman, Lars, Jones, Sari, Berger, Anna-Karin, Laukka, Erika Jonsson, Small, Brent J. · 2005 · Neuropsychology
4. Alzheimer’s Disease: Past, Present, and Future
   Bondi, Mark W., Edmonds, Emily C., Salmon, David P. · 2017 · Journal of the International Neuropsychological Society
5. Apolipoprotein E and Cognitive Performance: A Meta-Analysis.
   Small, Brent J., Rosnick, Christopher B., Fratiglioni, Laura, Bäckman, Lars · 2004 · Psychology and Aging
6. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis
   Nick M. Wisdom, Jennifer L. Callahan, Keith A. Hawkins · 2009 · Neurobiology of Aging
7. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
   Bondi, Mark W., Houston, Wes S., Eyler, Lisa T., Brown, Gregory G. · 2005 · Neurology
8. Multiple cognitive deficits during the transition to Alzheimer's disease
   Lars Bäckman, Sari Jones, Anna‐Karin Berger, Erika J Laukka, Brent J. Small · 2004 · Journal of Internal Medicine
9. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
   Elizabeth W. Twamley, Susan Ropacki, Mark William Bondi · 2006 · Journal of the International Neuropsychological Society
10. The role of APOE -ε4 in longitudinal cognitive decline
    P. Bretsky, Jack M. Guralnik, Lenore J. Launer, Marilyn Albert, Teresa E. Seeman · 2003 · Neurology
11. Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment
    Edmonds, Emily C., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Bondi, Mark W. · 2014 · Journal of the International Neuropsychological Society
12. Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment.
    Maureen Schmitter‐Edgecombe, Ellen Woo, David R. Greeley · 2009 · Neuropsychology
13. Memory and mental status correlates of modified Braak staging
    Ellen H. Grober, Dennis W. Dickson, Martin J. Sliwinski, Herman Buschke L, M Katz, Howard Crystal, Richard B. Lipton · 1999 · Neurobiology of Aging
14. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups
    Fleisher, Adam S., Sherzai, Ayesha, Taylor, Curtis, Langbaum, Jessica B.S., Chen, Kewei, Buxton, Richard B. · 2009 · NeuroImage
15. Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease
    Bondi, Mark W., Jak, Amy J., Delano-Wood, Lisa, Jacobson, Mark W., Delis, Dean C., Salmon, David P. · 2008 · Neuropsychology Review
16. Attention and Executive Control Predict Alzheimer Disease in Late Life: Results From the Berlin Aging Study (BASE)
    Michael A. Rapp, Friedel Martin Reischies · 2005 · American Journal of Geriatric Psychiatry
17. The Apolipoprotein E ϵ4 Allele and Decline in Different Cognitive Systems During a 6-Year Period
    Robert Smith Wilson, Julie A. Schneider, Lisa Laverne Barnes, Laurel A. Beckett, Neelum T. Aggarwal, Elizabeth J. Cochran, Elizabeth Berry‐Kravis, Julie Bach, Jacob H. Fox, Denis A. Evans et al. · 2002 · Archives of Neurology
18. Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals
    Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., Katzman, R. · 2002 · Neurology
19. Effects of Apolipoprotein E Genotype on Spatial Attention, Working Memory, and Their Interaction in Healthy, Middle-Aged Adults: Results From the National Institute of Mental Health's BIOCARD Study.
    Pamela M. Greenwood, Chantal Lambert, Trey Sunderland, Raja Parasuraman · 2005 · Neuropsychology
20. APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
    M Clare O'Donoghue, Susannah Elinor Murphy, Giovanna Zamboni, Anna Christina Nobre, Clare E. Mackay · 2018 · Cortex
21. Cognitive and neuropathologic correlates of Stroop Color-Word Test performance in Alzheimer's disease.
    Mark William Bondi, Adam B. Serody, Agnes Sui-Yin Chan, Sonja Eberson, Dean C. Delis, Lawrence A. Hansen, David P. Salmon · 2002 · Neuropsychology
22. Specific Measures of Executive Function Predict Cognitive Decline in Older Adults
    Lindsay R. Clark, Dawn M. Schiehser, Gali H. Weissberger, David P. Salmon, Dean C. Delis, Mark William Bondi · 2011 · Journal of the International Neuropsychological Society
23. Neuropsychological Performance in Patients With Depression is Associated With Clinical, Etiological and Genetic Risk Factors
    Sharon Linda Naismith, Ian Bernard Hickie, Keelin Turner, Craig L. Little, Virginia Winter, Philip B. Ward, Kay A Wilhelm, Philip Bowden Mitchell, Gordon Barraclough Parker · 2003 · Journal of Clinical and Experimental Neuropsychology
24. Apolipoprotein E and cholesterol in aging and disease in the brain
    de Chaves, Elena Posse, Narayanaswami, Vasanthy, Christoffersen, Christina, Nielsen, Lars Bo · 2008 · Future Lipidology
25. Trajectory of mild cognitive impairment onset
    Diane B. Howieson, Nichole E. Carlson, Milar M. Moore, Dara K Wasserman, CENA D. ABENDROTH, Jessica C. Payne-Murphy, Jeffrey Alan Kaye · 2008 · Journal of the International Neuropsychological Society
26. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
    Pierre Celsis · 2000 · Annals of Medicine
27. Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E
    Richard P Mayeux, Scott A. Small, Ming‐Xin Tang, Benjamin Tycko, Yaakov Stern · 2001 · Neurobiology of Aging
28. Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology
    DELANO-WOOD, LISA, BONDI, MARK W., SACCO, JOSHUA, ABELES, NORM, JAK, AMY J., LIBON, DAVID J., BOZOKI, ANDREA · 2009 · Journal of the International Neuropsychological Society
29. Genes, Environment, and Time: The Vietnam Era Twin Study of Aging (VETSA)
    William S. Kremen, Heather Thompson‐Brenner, Yat-Ming J. Leung, Michael D. Grant, Carol E. Franz, Seth A. Eisen, Kristen C. Jacobson, Corwin Boake, Michael J. Lyons · 2006 · Twin Research and Human Genetics
30. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis
    S. Duke Han, Mark William Bondi · 2008 · Alzheimer s & Dementia
31. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration
    Kelsey R. Thomas, Katherine J. Bangen, Alexandra J. Weigand, Emily C. Edmonds, Christina G. Wong, Shanna Cooper, Lisa Delano‐Wood, Mark William Bondi, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Neurology
32. Genetics and visual attention: Selective deficits in healthy adult carriers of the ɛ4 allele of the apolipoprotein E gene
    Pamela M. Greenwood, Trey Sunderland, Judy Friz, Raja Parasuraman · 2000 · Proceedings of the National Academy of Sciences
33. Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease
    John Olichney · 2002 · Journal of Neurology Neurosurgery & Psychiatry
34. The influence of apoe status on episodic and semantic memory: Data from a population-based study.
    Lars‐Göran Nilsson, Rolf Adolfsson, Lars Bäckman, Marc Cruts, Lars H Nyberg, Brent J. Small, Christine Van Broeckhoven · 2006 · Neuropsychology
35. Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype
    LANGE, KELLY L., BONDI, MARK W., SALMON, DAVID P., GALASKO, DOUGLAS, DELIS, DEAN C., THOMAS, RONALD G., THAL, LEON J. · 2002 · Journal of the International Neuropsychological Society
36. Working memory and apolipoprotein E: What's the connection?
    Virginia M. Rosen · 2002 · Neuropsychologia
37. The apolipoprotein E gene, attention, and brain function.
    Raja Parasuraman, Pamela M. Greenwood, Trey Sunderland · 2002 · Neuropsychology
38. Is APOE -ε4 a risk factor for cognitive impairment in normal aging?
    Brent J. Small, Amy Borenstein Graves, Cathy L. McEvoy, Fiona Crawford, MICHAEL J. MULLAN, James A. Mortimer · 2000 · Neurology
39. APOE-ε4 is associated with memory decline in cognitively impaired elderly
    Miranda G. Dik, Cees Jonker, L.M. Bouter, Mirjam I. Geerlings, Gerard J. van Kamp, Dorly J. H. Deeg · 2000 · Neurology
40. Interaction of Age and APOE Genotype on Cerebral Blood Flow at Rest
    Christina E. Wierenga, Lindsay R. Clark, Sheena Isha Dev, David D. Shin, Sarah M. Jurick, Robert A. Rissman, Thomas T. Liu, Mark William Bondi · 2013 · Journal of Alzheimer s Disease
41. The Aging Hippocampus: Navigating Between Rat and Human Experiments
    Ira Frahmand Driscoll, Robert J. Sutherland · 2005 · Reviews in the Neurosciences
42. Verbal Serial List Learning in Mild Cognitive Impairment: A Profile Analysis of Interference, Forgetting, and Errors
    David J. Libon, Mark William Bondi, Catherine C. Price, Melissa Lamar, Joel S. Eppig, Denene M. Wambach, Christine Nieves, Lisa Delano‐Wood, Tania Giovannetti, Carol Frances Lippa et al. · 2011 · Journal of the International Neuropsychological Society
43. The Effects of Prolonged Stress and APOE Genotype on Memory and Cortisol in Older Adults
    Guerry M. Peavy, Kelly L. Lange, David P. Salmon, Thomas L. Patterson, Sherry Goldman, Anthony C. Gamst, Paul J. Mills, Srikrishna Khandrika, Douglas R Galasko · 2007 · Biological Psychiatry
44. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging
    David J. Bunce, Laura Fratiglioni, Brent J. Small, Bengt G. Winblad, Lars Bäckman · 2004 · Neurology
45. APOE Genotype Modifies the Relationship between Midlife Vascular Risk Factors and Later Cognitive Decline
    Katherine J. Bangen, Alexa Beiser, Lisa Delano‐Wood, Daniel A. Nation, Melissa Lamar, David J. Libon, Mark William Bondi, Sudha S. Seshadri, Philip A. Wolf, Rhoda Au · 2013 · Journal of Stroke and Cerebrovascular Diseases
46. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease
    Kejal Kantarci, Glenn E. Smith, Robert J. Ivnik, Ronald Carl Petersen, Bradley F. Boeve, David S. Knopman, Eric G. Tangalos, Clifford R. Jack · 2002 · Journal of the International Neuropsychological Society
47. Normal Genetic Variation, Cognition, and Aging
    Pamela M. Greenwood, Raja Parasuraman · 2003 · Behavioral and Cognitive Neuroscience Reviews
48. APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures
    Jennifer M. Rusted, Simon Evans, Sarah L. King, Nicholas G. Dowell, Naji Tabet, Paul S. Tofts · 2012 · NeuroImage
49. Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease
    Christina E. Wierenga, Mark William Bondi · 2007 · Neuropsychology Review
50. Hippocampal volumes are important predictors for memory function in elderly women
    Martin A Ystad, Astri Johansen Lundervold, Eike Ines Wehling, Thomas Espeseth, Helge Rootwelt, Lars Tjelta Westlye, Martin Andersson, Steinunn Adólfsdóttir, Jonn Terje Geitung, Anders M. Fjell et al. · 2009 · BMC Medical Imaging
51. Natural history of Alzheimer’s disease
    Lawrence S. Honig, Richard P Mayeux · 2001 · Aging Clinical and Experimental Research
52. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment
    Kelsey R. Thomas, Emily C. Edmonds, Joel S. Eppig, David P. Salmon, Mark William Bondi, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Journal of Alzheimer s Disease
53. Mild cognitive impairment: Conceptual issues and structural and functional brain correlates
    Andrew J. Saykin, Heather A. Wishart · 2003 · Seminars in Clinical Neuropsychiatry
54. APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study
    Hadassa M. Jochemsen, Majon Muller, Yolanda van der Graaf, Mirjam I. Geerlings · 2011 · Neurobiology of Aging
55. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults
    Thomas Espeseth, Pamela M. Greenwood, Ivar Reinvang, Anders M. Fjell, Kristine Beate Walhovd, Lars Tjelta Westlye, Eike Ines Wehling, Astri Johansen Lundervold, Helge Rootwelt, Raja Parasuraman · 2006 · Cognitive Affective & Behavioral Neuroscience
56. Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease
    Yu‐Ling Chang, Mark William Bondi, Christine Fennema‐Notestine, Linda K. McEvoy, Donald J. Hagler, Mark W. Jacobson, Anders Martin Dale · 2009 · Neuropsychologia
57. Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease
    Pablo Galeano, Pamela V. Martino Adami, Sonia Do Carmo, Eduardo Blanco, Cecilia Rotondaro, Francisco Capani, Eduardo Miguel Castaño, A. Claudio Cuello, Laura Morelli · 2014 · Frontiers in Behavioral Neuroscience
58. Stroke and Apolipoprotein E ε4 Are Independent Risk Factors for Cognitive Decline
    Miranda G. Dik, Dorly J. H. Deeg, L.M. Bouter, Elizabeth H. Corder, Astrid Kok, Cees Jonker · 2000 · Stroke
59. Word-list intrusion errors predict progression to mild cognitive impairment.
    Kelsey R. Thomas, The Alzheimer’s Disease Neuroimaging Initiative*, Joel S. Eppig, Emily C. Edmonds, Diane M. Jacobs, David J. Libon, Rhoda Au, David P. Salmon, Mark William Bondi · 2018 · Neuropsychology
60. Neuropsychological decline up to 20 years before incident mild cognitive impairment
    Richard J. Caselli, Blake Langlais, Amylou Constance Dueck, Yinghua Chen, Yi Su, Dona E.C. Locke, Bryan Keith Woodruff, Eric M. Reiman · 2019 · Alzheimer s & Dementia
61. Individual Growth Curve Analysis of APOE ε4–Associated Cognitive Decline in Alzheimer Disease
    Brian D. Hoyt, Paul J. Massman, Christopher W. Schatschneider, Norma Cooke, Rachelle Smith Doody · 2005 · Archives of Neurology
62. Correlates of personal concerns about developing Alzheimer's disease among middle-aged persons
    Cutler, Stephen J., Hodgson, Lynne G. · 2001 · American Journal of Alzheimer's Disease & Other Dementias®
63. Prospective memory and apolipoprotein e in healthy aging and early stage Alzheimer's disease.
    Janet M. Duchek, David A. Balota, Michael J. Cortese · 2006 · Neuropsychology
64. Neuropsychological Features of Mild Cognitive Impairment and Preclinical Alzheimer’s Disease
    Salmon, David P. · 2011 · Current Topics in Behavioral Neurosciences
65. Spatial Navigation and APOE in Amnestic Mild Cognitive Impairment
    Jan Laczó, Ross Andel, Kamil Vlček, Václav Macoška, Martin Vyhnálek, Martin Tolar, Martin Bojar, Jakub Hort · 2010 · Neurodegenerative Diseases
66. Less efficient pattern separation may contribute to age-related spatial memory deficits
    Heather M. Holden, Paul E. Gilbert · 2012 · Frontiers in Aging Neuroscience
67. Comparison of the serial position effect in very mild Alzheimer's disease, mild Alzheimer's disease, and amnesia associated with electroconvulsive therapy
    Peter J. Bayley, David P. Salmon, Mark William Bondi, Barbara Kathleen Bui, John Olichney, Dean C. Delis, Ronald G. Thomas, Leon J. Thal · 2000 · Journal of the International Neuropsychological Society
68. Effects of sex and APOE ε4 on object recognition and spatial navigation in the elderly
    Frederique Berteau-Pavy, Brian Park, Jacob Raber · 2007 · Neuroscience
69. β-Peptide Immunization
    Dale B. Schenk, Peter A. Seubert, Ivan M. Lieberburg, Jan Wallace · 2000 · Archives of Neurology
70. Apolipoprotein E Gene Variability and Cognitive Functions at Age 79: A Follow-Up of the Scottish Mental Survey of 1932.
    Ian J. Deary, Martha C. Whiteman, Alison Pattie, John M. Starr, Caroline Hayward, Alan F. Wright, Peter M. Visscher, Maria C. Tynan, Lawrence J. Whalley · 2004 · Psychology and Aging
71. Do neuropsychological tests detect preclinical Alzheimer's disease: Individual-test versus cognitive-discrepancy score analyses.
    Mark W. Jacobson, Dean C. Delis, Mark William Bondi, David P. Salmon · 2002 · Neuropsychology
72. A plateau in pre-Alzheimer memory decline
    Glenn E. Smith, V. Shane Pankratz, Selam Negash, Mary M. Machulda, Ronald Carl Petersen, Bradley F. Boeve, David S. Knopman, John Alexander Lucas, Tanis J. Ferman, Neill R. Graff‐Radford et al. · 2007 · Neurology
73. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease
    Yusuke Suzuki, Sayaka Yamamoto, Hiroyuki Umegaki, Joji Onishi, Nanaka Mogi, Hiroshige Fujishiro, Akihisa Iguchi · 2004 · International Journal of Geriatric Psychiatry
74. Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markers
    Erin E. Sundermann, My Tran, Pauline M. Maki, Mark William Bondi, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
75. Neuropsychological performance in advanced age: Influences of Demographic factors and Apolipoprotein E: Findings from the Cache County Memory Study
    Kathleen Anne Welsh-Bohmer, Truls Østbye, Linda L Sanders, Carl F. Pieper, Kathleen M. Hayden, JoAnn T. Tschanz, Maria C. Norton, for the Cache Country Study Group · 2008 · The Clinical Neuropsychologist
76. Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Is It Contributing to Higher Risk of Cognitive Decline and Coronary Heart Disease?
    Raphaël Chouinard‐Watkins, Mélanie Plourde · 2014 · Nutrients
77. Change in cognitive functioning associated with ApoE genotype in a community sample of older adults.
    Scott Michael Hofer, Helen M Christensen, Andrew James Mackinnon, Alisa E. Korten, Anthony Francis Jorm, Alexander S. Henderson, Simon Easteal · 2002 · Psychology and Aging
78. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful
    Jinzhou Tian · 2003 · Journal of Neurology Neurosurgery & Psychiatry
79. Rate of Cognitive Decline in Preclinical Alzheimer's Disease: The Role of Comorbidity
    Lars Bäckman, Sari Jones, Brent J. Small, Hedda Agüero‐Torres, Laura Fratiglioni · 2003 · The Journals of Gerontology Series B
80. The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample
    Helen M Christensen, Philip J. Batterham, Andrew James Mackinnon, Anthony Francis Jorm, Holly A. Mack, Karen A. Mather, Kaarin Jane Anstey, Perminder Singh Sachdev, Simon Easteal · 2008 · BMC Geriatrics
81. APOE Genotype and Cognitive Change in Young, Middle-Aged, and Older Adults Living in the Community
    David J. Bunce, Allison A. M. Bielak, Kaarin Jane Anstey, Nicolas Cherbuin, Philip J. Batterham, Simon Easteal · 2013 · The Journals of Gerontology Series A
82. Apolipoprotein E genotype and memory in the sixth decade of life
    Mark R. Schultz, Michael J. Lyons, Carol E. Franz, M. D. Grant, Corwin Boake, Kristen C. Jacobson, Hong Xian, Gerard D. Schellenberg, Seth A. Eisen, William S. Kremen · 2008 · Neurology
83. Executive functions in clinical and preclinical Alzheimer's disease
    Philippe Allain, Frédérique Etcharry‐Bouyx, Christophe Verny · 2013 · Revue Neurologique
84. The contribution of the study of neurodegenerative disorders to the understanding of human memory
    Panegyres, P.K. · 2004 · QJM
85. Apolipoprotein E and Prospective Memory in Normally Aging Adults.
    Ira Frahmand Driscoll, Mark A. McDaniel, Melissa J. Guynn · 2005 · Neuropsychology
86. Neurocognitive profiles in elderly patients with frontotemporal degeneration or major depressive disorder
    Virginia Elderkin‐Thompson, Kyle Brauer Boone, Sun Hwang, Anand Kumar · 2004 · Journal of the International Neuropsychological Society
87. Testosterone and cognitive function in ageing men: Data from the Florey Adelaide Male Ageing Study (FAMAS)
    Donel M Martin, Gary Wittert, Nicholas R. Burns, Matthew T. Haren, Roy Sugarman · 2007 · Maturitas
88. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease
    Julie A. Testa, Robert J. Ivnik, Bradley F. Boeve, Ronald Carl Petersen, V. Shane Pankratz, David S. Knopman, Eric G. Tangalos, Glenn E. Smith · 2004 · Journal of the International Neuropsychological Society
89. Hippocampal viscoelasticity and episodic memory performance in healthy older adults examined with magnetic resonance elastography
    Lucy V. Hiscox, Curtis L. Johnson, Matthew McGarry, Hillary D. Schwarb, Edwin J.R. van Beek, Neil Roberts, John M. Starr · 2018 · Brain Imaging and Behavior
90. Context-specific memory and apolipoprotein E (ApoE) ε4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease
    James A. Levy, Judy Bergeson, Karen T. Putnam, Virginia M. Rosen, Robert M. Cohen, François M. Lalonde, NADEEM MIRZA, Gary Linker, Trey Sunderland · 2004 · Journal of the International Neuropsychological Society
91. Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve
    Larry A. Tupler, Kousik Krishnan, Daniel L. Greenberg, Santica M. Marcovina, Martha E. Payne, James R. MacFall, H. Cecil Charles, Pudugramam Murali Doraiswamy · 2006 · Neurobiology of Aging
92. Deficits in Inhibition and Flexibility are Associated with the APOE-E4 Allele in Nondemented Older Adults
    Spencer Wetter, Dean C. Delis, Wes S. Houston, Mark W. Jacobson, Amy E. Lansing, Krystal Cobell, David P. Salmon, Mark William Bondi · 2005 · Journal of Clinical and Experimental Neuropsychology
93. Effect of the brain‐derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer’s disease
    Ryota Hashimoto, Yoko Hirata, Takashi Asada, Fumio Yamashita, Kiyotaka Nemoto, T. Mori, Yoshiya Moriguchi, Hiroshi Kunugi, K. Arima, Takashi Ohnishi · 2008 · Genes Brain & Behavior
94. APOE ε4, Alzheimer’s disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.
    Lei Yu, Patricia A. Boyle, Julie A. Schneider, Eisuke Segawa, Robert S. Wilson, Sue E. Leurgans, David Alan Bennett · 2013 · Psychology and Aging
95. Impact of APOE status on cognitive maintenance in healthy elderly persons
    Antoinette Zweifel-Zehnder, Stefan Bläsi, Manfred Berres, Andreas Urs Monsch, Hannes Benedikt Stähelin, René Spiegel · 2008 · International Journal of Geriatric Psychiatry
96. Effects of Family History and Apolipoprotein E ε4 Status on Cognitive Decline in the Absence of Alzheimer Dementia
    Kathleen M. Hayden · 2009 · Archives of Neurology
97. Serial position effects in Alzheimer's disease, mild cognitive impairment, and normal aging: Predictive value for conversion to dementia
    Catarina Cunha, Manuela Guerreiro, Alexandre de Mendonça, Paulo Eduardo Oliveira, Isabel J. Santana · 2012 · Journal of Clinical and Experimental Neuropsychology
98. Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: Verbal versus design fluency
    Wes S. Houston, Dean C. Delis, Amy E. Lansing, Mark W. Jacobson, Krystal Cobell, David P. Salmon, Mark William Bondi · 2005 · Journal of the International Neuropsychological Society
99. Effective Screening for Alzheimers Disease Among Older African Americans
    Benjamin T. Mast, Joseph Fitzgerald, Joel Steinberg, Susan E. MacNeill, Peter Alexander Lichtenberg · 2001 · The Clinical Neuropsychologist
100. Risk factors and early signs of Alzheimer's disease in a family study sample
     Reinhard Heun, Heike Kölsch, Frank Jessen · 2005 · European Archives of Psychiatry and Clinical Neuroscience